Rani Therapeutics Holdings, Inc. (RANI) Tops Q4 EPS by 11c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q4 EPS of ($0.27), $0.11 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• MIND Technology (MIND) Misses Q1 EPS by 5c